Table 5.

Multivariate analysis of clinical characteristics and dynamic cerebral autoregulation for favorable long-term outcome

Variables	Crude OR (95% CI)	P-value	Adjusted OR (95% CI)	P-value
Clinical factors
Fast blood glucose (mmol/L)	1.726 (1.171, 2.544)	0.006*	3.523 (1.255, 9.885)	0.017*
BMI	1.250 (1.027, 1.521)	0.026*		0.623
TG (mmol/L)	3.401 (0.937, 12.343)	0.063		0.760
CRP (mg/L)	1.088 (1.008,0.175)	0.031*		0.162
NIHSS on admission	1.276 (1.105, 1.474)	0.001*	1.825 (1.155, 2.886)	0.010*
Cerebral autoregulation
dCA on 24 h after onset
Phase on ipsilateral side	0.955 (0.926, 0.985)	0.004*	0.889 (0.813, 0.971)	0.009*
Phase on contralateral side	0.978 (0.956, 1.000)	0.048*		0.184
dCA on 72 h after onset
Phase on ipsilateral side	0.970 (0.942, 0.998)	0.039*		0.205
Phase on contralateral side	0.974 (0.948, 1.000)	0.053		0.183
dCA on 7d after onset
Phase on ipsilateral side	0.962 (0.923, 1.003)	0.069		0.259
Phase on contralateral side	0.979 (0.950, 1.010)	0.180

TG Triglyceride, BMI Body Mass Index, CRP Hypersensitive C-Reactive Protein, NIHSS National Institutes of Health Stroke Scale

^*significant difference in comparing between favourable-outcome group and unfavourable-outcome group, p < 0.05